메뉴 건너뛰기




Volumn 19, Issue 9, 2005, Pages 1696-1699

CIZ gene rearrangements in acute leukemia: Report of a diagnostic FISH assay and clinical features of nine patients [13]

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CD19 ANTIGEN; CD33 ANTIGEN; GENE PRODUCT; MICROSOMAL AMINOPEPTIDASE; PROTEIN CIZ; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG; TRANSACTIVATOR PROTEIN; ZNF384 PROTEIN, HUMAN;

EID: 26944442820     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2403842     Document Type: Letter
Times cited : (33)

References (4)
  • 1
    • 0036791118 scopus 로고    scopus 로고
    • Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia
    • Martini A, La Starza R, Janssen H, Bilhou-Nabera C, Corveleyn A, Somers R et al. Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. Cancer Res 2002; 62: 5408-5412.
    • (2002) Cancer Res , vol.62 , pp. 5408-5412
    • Martini, A.1    La Starza, R.2    Janssen, H.3    Bilhou-Nabera, C.4    Corveleyn, A.5    Somers, R.6
  • 2
    • 0026746009 scopus 로고
    • Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoint
    • Zucman J, Delattre O, Desmaze C, Plougastel B, Joubert I, Melot T et al. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoint. Genes Chromosomes Cancer 1992; 5: 271-277.
    • (1992) Genes Chromosomes Cancer , vol.5 , pp. 271-277
    • Zucman, J.1    Delattre, O.2    Desmaze, C.3    Plougastel, B.4    Joubert, I.5    Melot, T.6
  • 4
    • 0141567663 scopus 로고    scopus 로고
    • For the GIMEMA Group. Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: Absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome
    • Cimino G, Elia L, Mancini M, Annino L, Anaclerico B, Fazi P, et al., for the GIMEMA Group. Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: Absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. Blood 2003; 102: 2014-2020.
    • (2003) Blood , vol.102 , pp. 2014-2020
    • Cimino, G.1    Elia, L.2    Mancini, M.3    Annino, L.4    Anaclerico, B.5    Fazi, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.